ENGERIX-B Hepatitis B Vaccine

ENGERIX-B is a recombinant hepatitis B vaccine used to help protect adults, adolescents, and children against infection caused by all known subtypes of the hepatitis B virus. For clinics, occupational health programs, travel medicine practices, and hospital pharmacies, it is a core component of standard immunization protocols and post-exposure prophylaxis planning.

Buyers sourcing ENGERIX-B typically want to confirm a few practical points before ordering. The vaccine is supplied in single-dose presentations and is given as an intramuscular injection, with separate pediatric/adolescent and adult formulations distinguished by antigen dose. It follows a standard multi-dose schedule administered over several months, with an accelerated schedule available for situations requiring rapid protection, such as imminent travel or documented exposure. Because it is a recombinant vaccine rather than a blood-derived product, it cannot cause hepatitis B infection.

Proper handling matters as much as the product itself. ENGERIX-B must be stored refrigerated within the manufacturer's recommended temperature range and must never be frozen; freezing renders it unusable. Facilities maintaining cold-chain integrity, documenting lot numbers, and tracking multi-dose completion see the strongest immunization outcomes. Ordering teams often plan quantities around patient cohorts and full-series completion rather than single doses, since protection depends on finishing the schedule.

As a prescription biologic, ENGERIX-B is intended for administration by qualified healthcare professionals following current clinical guidance and product labeling. If you manage a vaccination program and need to confirm current availability, formulation, or packaging options for your setting, our team can help you order with confidence.